Drawing for RAYHUNTA

USPTO serial 79270919

RAYHUNTA

Reviewed by CopyMark Law Group

Reg. 6207918Status 700Renewal
Filing date
Status date
Registration date
Dec 1, 2020
Examiner
DUBOIS, SUSAN L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RAYHUNTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher I. Donahue

Christopher I. Donahue Oblon McClelland Maier & Neustadt LLP1970 Duke StreetAlexandria, WA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of peripheral nervous system disorders; pharmaceutical preparations for the treatment of growth deficiencies; pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of Fabry disease, Gaucher disease, GM1 Gangliosidosis, GM2 Gangliosidosis, Krabbe disease, Niemann-Pick disease, Metachromatic leukodystrophy, Hurier syndrome, Hunter disease, Sanfilippo syndrome, Morquio syndrome, Sly syndrome, Pompe disease, Alfa-mannosidosis disease, Fucosidosis disease, and Neuronal ceroid lipofuscinosisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 1, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 28, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 8, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 8, 2021FIMPFINAL DISPOSITION PROCESSED—
Mar 1, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 1, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 15, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 15, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 10, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 16, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 2, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 2020ALIEASSIGNED TO LIE—
Feb 20, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 20, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 20, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 20, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 28, 2019RFNTREFUSAL PROCESSED BY IB—
Dec 6, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 5, 2019RFRRREFUSAL PROCESSED BY MPU—
Nov 13, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 12, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 8, 2019DOCKASSIGNED TO EXAMINER—
Nov 8, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 31, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance